Instructions to Authors

You are here: Home / Instructions to Authors

Author Guidelines

  • Authors are welcome to submit manuscripts on clinical, academic and laboratory research in the Health Sciences field.
  • By initiating the submission process authors agree to abide by Journal Copyright policy (The Creative Commons Attribution License 4.0) formalizes these and other terms and conditions of publishing articles).
  • The Journal requires authors to be in compliance with the Uniform Requirements for Manuscripts Submitted to Biomedical Journals (URMs), which are compiled by the International Committee of Medical Journal Editors (ICMJE), current URMs are available at
    Manuscripts should be submitted by one of the authors of the manuscript through the online submission system at or mail to
    The files can be submitted as a Word (.doc or .docx).The submitting author takes responsibility for the paper during submission and peer review.
    Papers must not have been published previously and should not be currently under consideration in totality or in part by another publication house/journal in print or electronic format (except in abstract or poster form).
The following documents must be included in your submission:
  1. Title Page & Covering Letter
  2. Author Contribution & Conflicts of Interest Statement form
  3. Manuscript
1. Title Page with Covering Letter
  1. Type of Manuscript and Title of the manuscript with a short running title (to be used as a header for each page).
  2. Authors in order, Corresponding author details (full name and the institutions with which they are affiliated, E-mail ID, mailing address & telephone number).
2. Author Contribution & Disclosure of Conflicts of Interest

Each author’s contribution to the manuscript and all potential or actual conflicts of interest present should also be listed to ensure smooth publication.

IDMJAR editors strive to ensure that what is published in the Journal is as balanced, objective and evidence-based as possible. The Journal requires authors to disclose all and any potential conflicts of interest. Conflicts of interest may be financial or non-financial. Financial conflicts include financial relationships such as honoraria; educational grants; participation in speakers' bureaus; membership, employment, consultancies, stock ownership, or other equity interest; expert testimony or patent-licensing arrangements.

Non-financial conflicts include personal or professional relationships, affiliations, academic competition, intellectual passion, knowledge or beliefs that might affect objectivity.

Please use the IDMJAR Author Contribution & Conflicts of Interest Statement form that is provided on the Journals website. (Click here)

3. Manuscript

Articles should be written in English, using American English spelling, and meet the following basic criteria: The material is original, the information is important, the writing is clear and concise, the study methods are appropriate, the data are valid, and the conclusions are reasonable and supported by the data.

Text should be typed double-spaced with a uniform margin using Calibri style and 12 size font, for subheadings use 14 size font. Avoid use of italicized words. Pages should be numbered consecutively, beginning with the abstract page.


An abstract (no longer than 400 words) and 5-8 relevant keywords (in alphabetical order) are required which should be taken from the Medical Subject Headings (MeSH) (
Abstracts for Original Research, Systematic Reviews & Meta-Analysis should be structured into the following sections.

  • Background: Briefly explain the importance of the study topic.
  • Aim: State a precise study question or purpose.
  • Methodology: Introduce the methods used to perform the study; include information on the study design, setting, subjects, interventions, outcome measures and analyses as appropriate.
  • Results: Briefly present the significant results, with data and statistical details such as p values where appropriate; be sure that information in the abstract matches that in the main text.
  • Conclusion: State the meaning of your findings, being careful to address the study question directly and to confine your conclusions to aspects covered in the abstract; give equal emphasis to positive and negative findings.
  • Clinical Significance: State the clinical significance of your research, its impact on the society at large and contribution to health science.

Abstracts for Review Articles, Short Communications, Correspondence, Perspectives & Clinical Techniques should be structured with the following headings : Background – Aim – Conclusion – Clinical Significance

Letter to the editor does not require an abstract


The text for Original Research, Systematic Reviews & Meta-Analysis articles should be organized into the following sections: Introduction, Materials and methods/Methodology, Results, Discussion, Conclusion, Acknowledgments (If any), and References

  1. Abbreviations: Where a term/definition will be continually referred to, it must be written in full when it first appears in the text, followed by the subsequent abbreviation in parentheses. Thereafter, the abbreviation may be used. An abbreviation should not be first defined in any section heading; if an abbreviation has previously been defined in the text, then the abbreviation may be used in a subsequent section heading. Restrict the number of abbreviations to those that are absolutely necessary and ensure consistency of abbreviations throughout the article.
  2. Numbers: Numbers that begin a sentence or those that are less than 10 should be spelled out using letters. Centuries and decades should be spelled out, e.g., the eighties or nineteenth century. Laboratory parameters, time, temperature, length, area, mass, and volume should be expressed using digits.
  3. Units of measurements: Units should be in System International (SI) units.
  4. Names of devices, other products and drugs: For devices and other products, the specific brand or trade name, the manufacturer and their location (city, state, country) should be provided the first time the device or product is mentioned in the text, for example, "SPSS version 10.0 was used (SPSS Inc., Chicago, IL, USA)". Thereafter, the generic term (if appropriate) should be used.
    Use the Recommended International Nonproprietary Name (rINN) for medicinal substances, unless the specific trade name of a drug is directly relevant to the discussion. Generic drug names should appear in lowercase letters in the text. If a specific proprietary drug needs to be identified, the brand name may appear only once in the manuscript in parentheses following the generic name the first time the drug is mentioned in the text.
  5. Tables: Tables should supplement, not duplicate, the text. They should have a concise table heading, be self-explanatory, and numbered consecutively in the order of their citation in the text. Items requiring explanatory footnotes should be denoted using superscripted lowercase letters (a, b, c, etc.), with the footnotes arranged under the table in alphabetical order. Asterisks (*, **) are used only to indicate the probability level of tests of significance. Abbreviations used in the table must be defined and placed after the footnotes in alphabetical order. If you include a block of data or table from another source, whether published or unpublished, you must acknowledge the original source.
  6. Figures: The number of figures should be restricted to the minimum necessary to support the textual material. Figures should have an informative figure legend and be numbered in the order of their citation in the text.
    All symbols and abbreviations should be defined in the figure legend in alphabetical order.
    Items requiring explanatory footnotes should follow the same style as that for tables. Photomicrographs must include an internal scale marker, and the legend should state the type of specimen, original magnification and stain.
    Figures must be submitted as separate picture files at the correct resolution. The files should be named according to the figure number, e.g., Fig1.tif, Fig2.jpg.Figures should be supplied in either vector art formats (Illustrator, EPS, WMF, FreeHand, Corel Draw, PowerPoint, Excel, etc.) or bitmap formats (Photoshop, TIFF, GIF, JPEG, etc.)
  7. Statistical requirements: Statistical analysis is essential for all Original Research Papers correct nomenclature of statistical methods (e.g., two sample t test, not unpaired t test). Descriptive statistics should follow the scales used in data description. Inferential statistics are important for interpreting results and have be described in detail.
    All p values should be presented to the third decimal place for accuracy. The smallest p value that should be expressed is p < 0.001, since additional zeros do not convey useful information; the largest p value that should be expressed is p > 0.99.

Authors are responsible for the accuracy and completeness of their references and for correct in-text citation. If massive corrections of references are found to be necessary in the event that your manuscript is accepted, IDMJAR editors reserve the right to overturn the decision and reject the article.


Authors are responsible for the accuracy and completeness of their references and for correct in-text citation. If massive corrections of references are found to be necessary in the event that your manuscript is accepted, IDMJAR editors reserve the right to overturn the decision and reject the article.

1. In the main text, tables, figure legends:
  • References should be indicated by superscripted numbers according to order of appearance in the text, and placed after punctuation. [The actual authors can be referred to, but the reference number(s) must always be given.]
  • References cited in tables or figure legends should be included in sequence at the point where the table or figure is first mentioned in the main text.
  • Do not cite abstracts unless they are the only available reference to an important concept.
  • Do not cite uncompleted work or work that has not yet been accepted for publication (i.e., unpublished observation, personal communication) as references.
2. In the references list (Vancouver Style)
  • References should be limited to those cited in the text and listed in numerical order.
  • References should include, in order, author’s surnames and initials, article title, abbreviated journal name, year, volume and page numbers.
  • The surnames and initials of all the authors up to 6 should be included, but when authors number 7 or more, list the first 6 authors only followed by et al.
  • Abbreviations for journal names should conform to those used in MEDLINE.
  • If citing a website, provide the author information, article title, website address and the date you accessed the information.
  • Reference to an article that is in press must state the journal name and, if possible, the year and volume.
Examples of the most common reference types are provided below. (Please pay particular attention to the formatting, word capitalization, spacing and style)

Standard journal articles
Lin SS, Lai JP, Yen YY, Chen IC, Kuo AH, Yeh IC. Investigation into the prediction accuracy of photo cephalometry for skeletal Class III adult female patients treated with two-jaw surgery. J Dent Sci 2012;7:137-47.

Napoli C, Trerotoli P, Solinas G, et al. Caries experience among adolescents in southeast Italy. J Dent Sci 2012;7:89-93.

Journal supplement
Kaplan NM. The endothelium as prognostic factor and therapeutic target: what criteria should we apply? J Cardiovasc Pharmacol 1998;32(Suppl 3):S78–80.

Journal article not in English but with English abstract
Hofele C, Schwager-Schmitt M, Volkmann M. Prognostic value of antibodies against p53 in patients with oral squamous cell carcinoma-five years survival rate. Laryngo rhino otologie 2002;81:342-5. [In German, English abstract]

Book with edition
Bradley EL. Medical and Surgical Management. 2nd ed. Philadelphia: Saunders; 1982, p. 72–95.

Book with editors
Letheridge S, Cannon CR, editors. Bilingual Education: Teaching English as a Second Language. New York: Praeger; 1980.

Book chapter in book with editor and edition
Greaves M, Culligan DJ.Blood and bone marrow. In: Underwood JCE, editor. General and Systematic Pathology. 4th ed. London: Churchill Livingstone; 2004, p. 615–72.

Book series with editors
Wilson JG, Fraser FC, editors. Handbook of Teratology, vols. 1-4. New York: Plenum Press; 1977-1978.

World Health Organization. World Health Report 2002: Reducing Risk, Promoting Healthy Life. Geneva, Switzerland: World Health Organization; 2002.

Electronic publications
Duchin JS. Can preparedness for biological terrorism save us from pertussis? Arch Pediatr Adolesc Med 2004;158(2).
Available from:
[Date accessed: June 12, 2004]

Smeeth L, Iliffe S. Community screening for visual impairment in the elderly. Cochrane Database Syst Rev 2002(2):CD001054. doi:10.1002/14651858. CD1001054.

Items presented at a meeting but not yet published
Khuri FR, Lee JJ, Lippman SM. Isotretinoin effects on head and neck cancer recurrence and second primary tumors. In: Proceedings from the American Society of Clinical Oncology; May 31–June 3, 2003; Chicago, IL. Abstract 359.

Item presented at a meeting and published
Cionni RJ. Color perception in patients with UV- or blue-light-filtering IOLs. In: Symposium on Cataract, IOL, and Refractive Surgery. San Diego, CA: American Society of Cataract and Refractive Surgery; 2004. Abstract 337.

Ayers AJ. Retention of Resin Restorations by Means of Enamel Etching and by Pins.MSD thesis, Indiana University School of Dentistry, Indianapolis, 1971.

American Association of Oral and Maxillofacial Surgeons. Wisdom Teeth. Rosemont, IL: AAOMS, 2008. Available at: [Date accessed: November 15, 2008]

Company/manufacturer publication/pamphlet
Eastman Kodak Company, Eastman Organic Chemicals. Catalog no. 49. Rochester, NY: Eastman Kodak; 1977, p. 23.


Studies covering the use of human or animal samples in research, or human or animal experiments must be accompanied by a letter of approval from the appropriate Institutional Review Board or (Human Ethical Board or Animal Ethical Board committee).

Such approval should be stated in the methods section of the manuscript. For those investigators who do not have formal ethics review committees, the principles outlined in the Declaration of Helsinki should be followed (World Medical Association) should be followed. Declaration of Helsinki: ethical principles for medical research involving human subjects.

Available at

For investigations in humans, state explicitly in the methods section of the manuscript that informed consent was obtained from all participating adults and from parents or legal guardians for minors or incapacitated adults, together with the manner in which informed consent was obtained. Omitting data or making data less specific to de-identify patients is acceptable, but changing any such data is not acceptable.

Articles where human subjects can be identified in descriptions, photographs or pedigrees must be accompanied by a signed statement of informed consent to publish (in print and online) the descriptions, photographs and pedigrees from each subject who can be identified. IDMJAR Informed Consent Form (Click here)


All randomized controlled trials submitted for publication should include a completed Consolidated Standards of Reporting Trial flow chart (please go to for more information). The IDMJAR has adopted the ICMJE proposal that requires, as a condition of consideration for publication of clinical trials, registration in a public trials registry. Trials must register at or before the onset of patient enrolment. The clinical trial registration number should be included at the end of the abstract of the article.

For this purpose, a clinical trial is defined as any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects of health outcomes. Health-related interventions include any intervention used to modify a biomedical or health-related outcome (for example drugs, surgical procedures, devices, behavioral treatments, dietary interventions and process-of-care changes). Health outcomes include any biomedical or health-related measures obtained in patients or participants, including pharmacokinetic measures and adverse events.

Purely observational studies (those in which the assignment of the medical intervention is not at the discretion of the investigator) will not require registration. Further information can be found at


1. Original Research

These articles typically include randomized trials, intervention studies, studies of screening and diagnostic tests, laboratory and animal studies, cohort studies, cost-effectiveness analyses, case-control studies, and surveys with high response rates, which represent new and significant contributions to the field.
Section headings should be: Abstract, Introduction, Materials and methods, Results, Discussion, Conclusion, Acknowledgments (if any), and References.
The Introduction should provide a brief background to the subject of the paper, explain the importance of the study, and state a precise study question or purpose.
The Materials and methods section should describe the study design and methods (including the study setting and dates, patients/participants with inclusion and exclusion criteria, patient samples or animal specimens used, the essential features of any interventions, the main outcome measures, the laboratory methods followed, or data sources and how these were selected for the study), and state the statistical procedures employed in the research.
The Results section should comprise the study results presented in a logical sequence, supplemented by tables and/or figures. Take care that the text does not repeat data that are presented in tables and/or figures. Only emphasize and summarize the essential features of the main outcome measures, and the main results.
The Discussion section should be used to emphasize the new and important aspects of the study, placing the results in context with published literature, the implications of the findings, and the conclusions that follow from the study results.
(Upto 5000 words excluding abstract and references)

2. Review Articles

These should aim to cover aspects of a topic in which scientific consensus exists as well as aspects that remain controversial and are the subject of ongoing scientific research. All articles and data sources reviewed should include information about the specific type of study or analysis, population, intervention, exposure, and tests or outcomes. All articles or data sources should be selected systematically for inclusion in the review and critically evaluated.
(Upto 3500 words excluding abstract and references with a limit of 6 authors)

3. Systematic Review

Systematic review updates reconsider and bring previously published systematic reviews up to date. This allows authors to present changes to the review while avoiding unwarranted duplication in the literature. A guiding principle for an update is that it is an event that is discrete and distinct from the conduct and reporting of the original systematic review (or previously updated review). This means that at a minimum the search for studies will have been brought up to date and that any changes to the results and conclusions of the original review (or a previously updated review) are described. Systematic review updates will not usually warrant publication of a new full-length article. However, any published update will be an independent publication. It will not be part of the original review publication (or previously updated review).
(Upto 5000 words excluding abstract and references)

4. Meta- Analysis

Meta-analysis is a statistical technique for combining the findings from independent studies. Meta-analysis is most often used to assess the clinical effectiveness of healthcare interventions; it does this by combining data from two or more randomized control trials. Meta-analysis of trials should provide a precise estimate of treatment effect, giving due weight to the size of the different studies included. The validity of the meta-analysis depends on the quality of the systematic review on which it is based. A good meta-analyses paper should aim for complete coverage of all relevant studies, look for the presence of heterogeneity, and explore the robustness of the main findings using sensitivity analysis.
(Upto 5000 words excluding abstract and references)

5. Short Communication

These reports should be concise presentations of preliminary experimental results, instrumentation and analytical techniques, or aspects of clinical or experimental practice that are not fully investigated, verified or perfected but which may be of widespread interest or application.
The Editors reserve the right to decide what constitutes a Short Communication.
(Upto 1500 words, 10 references, 6 figures with a limit of 4 authors)

6. Correspondence

These include short case reports, technical or clinical notes and short comments on previously published articles.
(Upto 1500 words, 10 references, 6 figures with a limit of 4 authors)

7. Perspectives

These are comments on recent news or groundbreaking work and should provide a short review of the current state of research and explain the importance of the new findings. Perspectives on papers previously published should add a different viewpoint to the research and should not merely be a repetitive summary of the original paper.
(Upto 2500 words, 10 references, 6 figures with a limit of 4 authors)

8. Clinical Techniques

These reports should present a new experimental or computational method, test or procedure. The method described may either be completely new, or may offer a better version of an existing method. The article must describe a demonstrable advance on what is currently available. The method needs to have been well tested and ideally, but not necessarily, used in a way that proves its value.
(Upto 2500 words, 10 references, 6 figures with a limit of 4 authors)

9. Letter to the Editor

Brief letters of constructive comments in response to previously published IDMJAR articles are welcome. Letters are edited, sometimes extensively, to sharpen their focus. They may be sent for peer review at the discretion of IDMJAR editors. Letters are selected based on clarity, significance, and space.
(Upto 1000 words, 10 references, 2 figures with a limit of 4 authors)


The journal publishes articles on its website immediately on acceptance and follows a ‘CONTINUOUS PUBLICATION’ schedule.

Editorial Review: 2-3 days from initial submission for internal review and to learn whether the manuscript will be rejected or sent out for peer review. Manuscripts with insufficient originality, serious scientific flaws, or absence of importance of message are rejected.

Peer Review process: 2 weeks until all the reviews are received and the editors make a decision on whether the paper should be accepted, revised, or rejected based on reviews. Most papers are sent to two or three referees, but some are sent to more. Although we make every effort to ensure manuscripts are assessed fairly, IDMJAR is not responsible for the conduct of its referees. Occasionally, the reviewers may not be able to complete the review process within the set deadline. However, the final review process will definitely be completed within 2 weeks.

Revision: The revised version of the manuscript should be submitted within 3 days. However, there is no need to submit the “First Page” or “Copyright form” file while submitting a revised version. Please note that submission of a revised manuscript does not guarantee its acceptance by the journal. If we do not hear from you within this period, we will consider it your non-desire to continue the article with us and withdraw the manuscript.

Decision: 15 days (2 weeks on average) or less for final decision of provisional acceptance/rejection.

After Acceptance – Pre Proof - Copyediting

Once a manuscript has been accepted for publication and completed English editing, authors will receive a copyedited word document for technical and language check. It is the responsibility of the corresponding author to resubmit this copyedited file after desirable changes.

Proof Reading
Accepted manuscripts are then presented to the Publisher to be copyedited according to the Journal's style and the galley proofs in the form of a PDF file are sent by the Publisher to the corresponding author for final approval. Usually 3 rounds of proof reading are performed by the Editorial team.

Authors are responsible for all statements made in their work, including changes made by the copy editor. Proofreading is solely the authors' responsibility. Note that the Editorial Board reserves the right to make revisions to the manuscript and the Publisher may proceed with the publication of your article if no response from the author(s) is received.

Online Publishing
After completion of proof reading the manuscript will be uploaded online in the current issue at Authors will have free electronic access to the full text (PDF) of the article. Authors can freely download the PDF file from which they can print unlimited copies of their articles.


IDMJAR has no submission/processing/publication charges and is solely committed to the dissemination of scientific knowledge.

IDMJAR is an open access journal. Open access charges allow publishers to make the published material available for free to all interested online visitors.


We offer a reprint service for those requiring professional quality reproductions of articles. Reprints are produced from the final PDF of the article; if you are interested in reprints of an article, please email us at

Upto 500 copies of any article with a final PDF can be ordered which will be provided with a cover page. This simple to use service enables users to have reprints delivered to their door.